Intracare is a first mover in the $100B US biologic infusion market. Due to technology and expertise, between 50-75% of these type of outpatient hospital treatments can be done in the physician's office under the supervision as required by the complexity of care. The Company captures longitudinal data to create algorithms for better patient outcomes eg; lower re-admission rates, lower number of follow on surgeries and patient satisfaction.